BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Detry O, Govaerts L, Deroover A, Vandermeulen M, Meurisse N, Malenga S, Bletard N, Mbendi C, Lamproye A, Honoré P, Meunier P, Delwaide J, Hustinx R. Prognostic value of 18F-FDG PET/CT in liver transplantation for hepatocarcinoma. World J Gastroenterol 2015; 21(10): 3049-3054 [PMID: 25780305 DOI: 10.3748/wjg.v21.i10.3049]
URL: https://www.wjgnet.com/1007-9327/full/v21/i10/3049.htm
Number Citing Articles
1
Pedro Antonio Cascales-Campos, Pablo Ramírez Romero, Marcel André Schneider, Victor Lopez-Lopez, José Luis Navarro, Laura Frutos, Jose Antonio Pons Miñano, Pascual Parrilla Paricio. Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant?European Journal of Radiology 2017; 91: 155 doi: 10.1016/j.ejrad.2017.03.013
2
Zu-Fei Wang, Xiao-Xi Fan, Min Xu, Min-Jiang Chen, Zhong-Wei Zhao, Jun-Dong Zhou, Jian-Fei Tu, Jing-Jing Song, Xiang-Hua Hu, Chen-Ying Lu, Fa-Zong Wu, Deng-Ke Zhang, Li Chen, Lu Liu, Xi-Hui Ying, Xiao-Fei Xu, Jian-Song Ji. Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using 18F-fluorodeoxyglucose positron emission tomography/computed tomographyTumor Biology 2017; 39(5): 101042831770165 doi: 10.1177/1010428317701656
3
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data SystemJournal of Clinical and Experimental Hepatology 2019; 9(5): 625 doi: 10.1016/j.jceh.2019.07.005
4
Wei Zhang, Shao-Lv Lai, Jie Chen, Dong Xie, Fei-Xiang Wu, Guan-Qiao Jin, Dan-Ke Su. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrenceWorld Journal of Gastroenterology 2017; 23(35): 6467-6473 doi: 10.3748/wjg.v23.i35.6467
5
Xin’ai Wu, Jianbo Li, Cheng Wang, Guojian Zhang, Na Zheng, Xuemei Wang. Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic CarcinomaGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/8763205
6
Willy Liu, Jean Delwaide, Noella Bletard, Philippe Delvenne, Paul Meunier, Roland Hustinx, Olivier Detry. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case reportWorld Journal of Hepatology 2017; 9(11): 562-566 doi: 10.4254/wjh.v9.i11.562
7
Caio de Souza LEVY, Fernando Gomes de Barros COSTA, Daniele de Paula FARIA, Jose Tadeu STEFANO, Bruno COGLIATI, Claudia P OLIVEIRA. 18F-FDG PET/CT AS AN ASSESSMENT TOOL OF HEPATOCELLULAR CARCINOMA SECONDARY TO NON-ALCOHOLIC FATTY LIVER DISEASE DEVELOPMENT IN EXPERIMENTAL MODELArquivos de Gastroenterologia 2019; 56(1): 45 doi: 10.1590/s0004-2803.201900000-02
8
Edouard Reizine, Julia Chalaye, Sebastien Mule, Helene Regnault, Clara Perrin, Julien Calderaro, Alexis Laurent, Giuliana Amaddeo, Hicham Kobeiter, Vania Tacher, Emmanuel Itti, Alain Luciani. Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular CarcinomaAmerican Journal of Roentgenology 2022; 218(2): 359 doi: 10.2214/AJR.21.26485
9
G Dahlqvist, C Moreno, P Starkel, O Detry, L Coubeau, I Jochmans. Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC)Acta Gastro Enterologica Belgica 2021; 84(2): 347 doi: 10.51821/84.2.347
10
Astrid Bauschke, Annelore Altendorf-Hofmann, Lukas Brückner, Robert Drescher, Martin Freesmeyer, Utz Settmacher. Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2023; 149(4): 1401 doi: 10.1007/s00432-022-04009-x
11
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
12
Ryo Shimizu, Yoshiyuki Ida, Masayuki Kitano. Predicting Outcome after Percutaneous Ablation for Early-Stage Hepatocellular Carcinoma Using Various Imaging ModalitiesDiagnostics 2023; 13(19): 3058 doi: 10.3390/diagnostics13193058
13
Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S. Hussein, Ahmed A. El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M. Awad, Somaia A. Saad El-Din, Engi Elkholy, Dina R. D. Ibrahim, Shereen A. Saleh, Iman F. Montasser, Hany Said. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinomaEuropean Radiology 2018; 28(12): 5356 doi: 10.1007/s00330-018-5425-z
14
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee. Emerging role of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(11): 1289-1306 doi: 10.3748/wjg.v25.i11.1289
15
Ender Anılır, Alihan Oral, Fatih Turker, Tolga Şahin, Feyza Sönmez Topçu, Yıldıray Yuzer, Yaman Tokat. Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography–Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular CancerTransplantation Proceedings 2024; 56(1): 111 doi: 10.1016/j.transproceed.2023.12.007
16
Julia Greiser, Wolfgang Weigand, Martin Freesmeyer. Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the LiverPharmaceuticals 2019; 12(3): 137 doi: 10.3390/ph12030137
17
Helena Degroote, Eduard Callebout, Samuele Iesari, Jeroen Dekervel, Jonas Schreiber, Jacques Pirenne, Chris Verslype, Dirk Ysebaert, Peter Michielsen, Valerio Lucidi, Christophe Moreno, Olivier Detry, Jean Delwaide, Roberto Ivan Troisi, Jan Paul Lerut, Hans Van Vlierberghe. Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in BelgiumSurgical Oncology 2020; 33: 231 doi: 10.1016/j.suronc.2019.10.006
18
Md Ashraful Alam, Shouhei Hanaoka, Yukihiro Nomura, Tomohiro Kikuchi, Takahiro Nakao, Tomomi Takenaga, Naoto Hayashi, Takeharu Yoshikawa, Osamu Abe. Improved identification of tumors in 18F-FDG-PET examination by normalizing the standard uptake in the liver based on blood test dataInternational Journal of Computer Assisted Radiology and Surgery 2024; 19(3): 581 doi: 10.1007/s11548-023-03044-4
19
Anantha K. Nuthalapati, Steven I. Hanish, Paul J. Thuluvath. Disease Recurrence After Liver Transplantation2016; : 153 doi: 10.1007/978-1-4939-2947-4_11
20
Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(19): 10271 doi: 10.3390/ijms221910271
21
Dong-Wei Xu, Ping Wan, Qiang Xia. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewWorld Journal of Gastroenterology 2016; 22(12): 3325-3334 doi: 10.3748/wjg.v22.i12.3325
22
Pierre Lovinfosse, Roland Hustinx. Nuclear medicine techniques in transplantationClinical and Translational Imaging 2017; 5(1): 45 doi: 10.1007/s40336-016-0216-5
23
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approachesTherapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819836205
24
Justine Perrin, Karim Farid, Hilde Van Parijs, Olena Gorobets, Vincent Vinh-Hung, Nam P Nguyen, Navid Djassemi, Mark De Ridder, Hendrik Everaert. Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysisWorld Journal of Clinical Oncology 2022; 13(4): 287-302 doi: 10.5306/wjco.v13.i4.287
25
Fan Wu, Guohong Cao, Jinlan Lu, Shengli Ye, Xin Tang. Correlation between 18F-FDG PET/CT metabolic parameters and microvascular invasion before liver transplantation in patients with hepatocellular carcinomaNuclear Medicine Communications 2024; 45(12): 1033 doi: 10.1097/MNM.0000000000001897
26
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Giuseppe Mazzarella, Giuseppe Lucio Cascini. Microvascular Invasion in HCC: The Molecular Imaging PerspectiveContrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9487938
27
Harald Grut, Svein Dueland, Pål Dag Line, Mona Elisabeth Revheim. The prognostic value of 18F–FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastasesEuropean Journal of Nuclear Medicine and Molecular Imaging 2018; 45(2): 218 doi: 10.1007/s00259-017-3843-9
28
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysisAbdominal Radiology 2016; 41(1): 33 doi: 10.1007/s00261-015-0603-9
29
Sungmin Kang, Joo Dong Kim, Dong Lak Choi, Byungwook Choi. Predicting the Recurrence of Hepatocellular Carcinoma after Primary Living Donor Liver Transplantation Using Metabolic Parameters Obtained from 18F-FDG PET/CTJournal of Clinical Medicine 2022; 11(2): 354 doi: 10.3390/jcm11020354